EurekaMag.com logo
+ Translate

Electrophysiological effects of intravenous diltiazem. Experimental study in dogs


, : Electrophysiological effects of intravenous diltiazem. Experimental study in dogs. Revista Espanola de Cardiologia 39(5): 373-378

The study was carried out on 7 mongrel dogs anaesthetized with thipoental and open-chested. The electrophysiological effects of 0.2 mg/kg of diltiazem given. i.v. during one minute were studied. Two bipolar epicardial electrodes placed in the right atrium and one placed in the right ventricle were used to perform programmed stimulation and to obtain the atrial electrogram. The hisiogram was recorded using a catheter-electrode introduced through venous approach.

(PDF 0-2 workdays service)

Accession: 005349571

PMID: 3786905

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Dimich, I.; Profeta, J.; Jurado, R.; Chiang, H.; Kaplan, J.A., 1988: Reversal of the adverse cardiovascular effects of intravenous diltiazem in anesthetized dogs. Intravenous diltiazem can be used to treat myocardial ischemia, hypertension, and supraventricular dysrhythmias, but significant adverse effects including atrioventricular block and hypotension have been reported. At the present time, there is con...

Miyamoto, M.; Nishijima, Y.; Nakayama, T.; Hamlin, R.L., 2000: Cardiovascular effects of intravenous diltiazem in dogs with iatrogenic atrial fibrillation. Atrial fibrillation (AF) was induced in anaesthetized Beagle hounds to determine the dose of diltiazem (D) that resulted in haemodynamic function similar to that observed during sinus rhythm (SR). Dogs were instrumented to record haemodynamic and...

Leboeuf, J.; Lamar, J.C.; Massingham, R.; Ponsonnaille, J., 1989: Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem. 1. The electrophysiological effects of bepridil, its quaternary derivative, CERM 11888 (methylpyrrolidinium bromide) (both 2.5 mg kg-1 i.v.) and those of verapamil and diltiazem (0.2 mg kg-1 i.v.) were studied in closed chest anaesthetized dogs at...

Leboeuf J.; Lamar J.C.; Massingham R.; Ponsonnaille J., 1989: Electrophysiological effects of bepridil and its quaternary derivative cerm 11888 in closed chest anesthetized dogs a comparison with verapamil and diltiazem. The electrophysiological effects of bepridil, its quaternary derivative, CERM 11888 (methylpyrrolidinium bromide) (both 2.5 mg kg-1 i.v.) and those of verapamil and diltiazem (0.2 mg kg-1 i.v.) were studied in closed chest anaesthetized dogs at do...

Morena, H.; Pellet, J.; Denis, B.; Machecourt, J.; Wolf, J.E., 1982: Electrophysiological effects of diltiazem per os. Endocavitary study in man. Annales de Cardiologie et D'angeiologie 31(2): 149-154

Bai, Y.; Hu, L.; Wu, J.; Gu, Y.; Li, L.; Gao, B.; Jiang, H., 2013: Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism. The aim of this study was to assess the feasibility of evaluating the therapeutic effects of intravenous diltiazem in a newly established rat model of coronary thrombotic micro-embolism (CME). CME was induced by injecting 0.199 ml saline containin...

Anonymous, 1932: The effects observed following the intravenous and subcutaneous administratign of fluid An experimental study on dogs

Gelzer, A.R.M.; Kraus, M.S.; Rishniw, M.; Moïse, N.S.; Pariaut, R.; Jesty, S.A.; Hemsley, S.A., 2009: Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs. Atrial fibrillation (AF) with excessively high ventricular rates (VR) occurs in dogs with advanced heart disease. Rate control improves clinical signs in these patients. Optimal drug therapy and target VR remain poorly defined. Digoxin-diltiazem c...

Mitchell, L.B.; Jutzy, K.R.; Lewis, S.J.; Schroeder, J.S.; Mason, J.W., 1982: Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients. Fifteen patients without sinoatrial (SA) or atrioventricular (AV) node dysfunction underwent electrophysiologic study (EPS) before and after intravenous diltiazem: 0.20 mg/kg bolus followed by 0.0007 mg/kg/min infusion (seven patients) or 0.25 mg/...

Dougherty, A.H.; Jackman, W.M.; Naccarelli, G.V.; Friday, K.J.; Dias, V.C., 1992: Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group. Diltiazem has electrophysiologic effects similar to those of verapamil. Its efficacy and safety in 4 doses for treatment of induced supraventricular tachycardia (SVT) were examined and compared with those of placebo in 87 patients (25 with atriove...